Mineralys Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CATALYS PACIFIC, LLC | 11/14/2025 | 8.90 M | $337.63 M | 0.00% | 13.60% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 7.32 M | $277.72 M | 19.14% | 11.19% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2025 | 6.26 M | $237.50 M | 10.37% | 9.57% |
| BLACKROCK, INC. | 11/12/2025 | 3.67 M | $139.23 M | 18.52% | 5.61% |
| VANGUARD GROUP INC | 11/07/2025 | 3.02 M | $114.48 M | 29.77% | 4.61% |
| CALIGAN PARTNERS LP | 11/14/2025 | 2.77 M | $105.14 M | 37.44% | 4.24% |
| CAPITAL INTERNATIONAL INVESTORS | 11/13/2025 | 2.39 M | $90.76 M | -17.44% | 3.66% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 2.13 M | $80.85 M | 22.22% | 3.26% |
| SR ONE CAPITAL MANAGEMENT, LP | 11/12/2025 | 2.11 M | $80.16 M | -32.42% | 3.23% |
| FMR LLC | 11/13/2025 | 2.07 M | $78.54 M | 579.35% | 3.16% |
| CITADEL ADVISORS LLC | 11/14/2025 | 2.07 M | $78.39 M | 14,273.71% | 3.16% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 1.81 M | $68.63 M | 0.34% | 2.77% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 1.80 M | $68.24 M | 100.00% | 2.75% |
| LAURION CAPITAL MANAGEMENT LP | 11/17/2025 | 1.72 M | $65.24 M | -2.39% | 2.63% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.67 M | $63.44 M | 100.00% | 2.56% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2025 | 1.50 M | $56.88 M | -44.44% | 2.29% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 1.47 M | $55.72 M | 93.27% | 2.25% |
| MORGAN STANLEY | 11/14/2025 | 1.38 M | $52.22 M | 134.25% | 2.10% |
| STATE STREET CORP | 11/14/2025 | 1.30 M | $49.41 M | -9.74% | 1.99% |
| HOLOCENE ADVISORS, LP | 11/14/2025 | 1.21 M | $45.71 M | 100.00% | 1.84% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.12 M | $42.61 M | 17.69% | 1.72% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 1.06 M | $40.15 M | 100.00% | 1.62% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 942.63 K | $35.74 M | 15.39% | 1.44% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 929.17 K | $35.23 M | -26.72% | 1.42% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 882.42 K | $33.46 M | 3,160.11% | 1.35% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 879.68 K | $33.36 M | 5.38% | 1.34% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 783.45 K | $29.71 M | 578.61% | 1.20% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 768.27 K | $29.13 M | 191.72% | 1.17% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 750.00 K | $28.44 M | -16.67% | 1.15% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 711.66 K | $26.99 M | 13.54% | 1.09% |
| BARCLAYS PLC | 11/12/2025 | 653.83 K | $24.79 M | 354.41% | 1.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 626.15 K | $23.74 M | 15,142.16% | 0.96% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 610.92 K | $23.17 M | 6.39% | 0.93% |
| CANDRIAM S.C.A. | 11/06/2025 | 567.78 K | $21.53 M | -31.11% | 0.87% |
| PALE FIRE CAPITAL SE | 11/13/2025 | 532.41 K | $20.19 M | 19.21% | 0.81% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 507.65 K | $19.25 M | 185.20% | 0.78% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 455.52 K | $17.27 M | -1.74% | 0.70% |
| NEARWATER CAPITAL MARKETS, LTD | 11/13/2025 | 450.00 K | $17.06 M | 100.00% | 0.69% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 409.19 K | $15.52 M | 26.21% | 0.63% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 408.31 K | $15.48 M | 25.82% | 0.62% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 404.59 K | $15.34 M | 66.11% | 0.62% |
| NORTHERN TRUST CORP | 11/14/2025 | 390.81 K | $14.82 M | 15.27% | 0.60% |
| JENNISON ASSOCIATES LLC | 10/30/2025 | 376.35 K | $14.27 M | -69.53% | 0.58% |
| 22NW, LP | 11/14/2025 | 358.33 K | $13.59 M | -36.02% | 0.55% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 320.00 K | $12.13 M | 540.00% | 0.49% |
| SWEDBANK AB | 10/15/2025 | 299.30 K | $11.35 M | -22.02% | 0.46% |
| FINDELL CAPITAL MANAGEMENT LLC | 11/14/2025 | 250.00 K | $9.48 M | 100.00% | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2025 | 219.91 K | $8.34 M | -54.28% | 0.34% |
| SIMPLIFY ASSET MANAGEMENT INC. | 10/20/2025 | 218.73 K | $8.29 M | 100.00% | 0.33% |
| HIGHVISTA STRATEGIES LLC | 11/14/2025 | 209.83 K | $7.96 M | 39.76% | 0.32% |
Mineralys Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 214 institutional investors and hedge funds held shares of Mineralys Therapeutics, Inc.. The most heavily invested institutionals were:
Catalys Pacific, LLC: 8.9 M
RA CAPITAL MANAGEMENT, L.P.: 7.32 M
Samsara BioCapital, LLC: 6.26 M
BlackRock, Inc.: 3.67 M
VANGUARD GROUP INC: 3.02 M
Caligan Partners LP: 2.77 M
121.41% of Mineralys Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 82.15 M shares in the last 24 months. This purchase volume represents approximately $3.13 B in transactions.